TNYA
Tenaya Therapeutics Inc.
$1.41
$0.00(0.00%)
25
Overall
--
Value
25
Tech
--
Quality
Market Cap
$229.80M
Volume
2.78M
52W Range
$0.36 - $4.01
Target Price
$10.14
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $72.8M | $125.6M | $131.2M | $115.9M | ||
| Research & Development | $54.4M | $94.5M | $98.0M | $86.7M | ||
| Research Expense | $54.4M | $94.5M | $98.0M | $86.7M | ||
| Selling, General & Administrative | $18.4M | $31.1M | $33.2M | $29.2M | ||
| General & Administrative Expenses | $18.4M | $31.1M | $33.2M | $29.2M | ||
| Salaries & Wages | -- | -- | $15.3M | $16.5M | ||
| Depreciation & Amortization | $3.0M | $6.5M | $8.7M | $8.5M | ||
| Depreciation & Amortization | $3.0M | $6.5M | $8.7M | $8.5M | ||
| Other Operating Expenses | $-901.0K | $-1.6M | $-1.4M | $-1.4M | ||
| OPERATING INCOME | ||||||
| Operating income | $-72.8M | $-125.6M | $-131.2M | $-115.9M | ||
| EBITDA | $-68.6M | $-119.2M | $-112.0M | $-99.5M | ||
| NON-OPERATING ITEMS | ||||||
| Intinc | $108.0K | $2.0M | $7.1M | $4.7M | ||
| Net Non-Operating Interest Income/Expense | $108.0K | $2.0M | $7.1M | $4.7M | ||
| Other Income/Expense | $23.0K | $2.0K | $-53.0K | $-82.0K | ||
| Other Special Charges | $-23.0K | $2.0K | $53.0K | $82.0K | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-72.7M | $-125.6M | $-124.1M | $-111.1M | ||
| Pre-Tax Income | $-72.7M | $-123.7M | $-124.1M | $-111.1M | ||
| NET INCOME | ||||||
| Net Income | $-72.7M | $-123.7M | $-124.1M | $-111.1M | ||
| Net Income (Continuing Operations) | $-72.7M | $-123.7M | $-124.1M | $-111.1M | ||
| Net Income (Discontinued Operations) | $-72.7M | $-123.7M | $-124.1M | $-111.1M | ||
| Net Income (Common Stockholders) | $-72.7M | $-123.7M | $-124.1M | $-111.1M | ||
| Normalized Income | $-57.4M | -- | -- | $-110.0M | ||
| TOTALS | ||||||
| Total Expenses | $72.8M | $125.6M | $131.2M | $115.9M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $17.7M | $44.8M | $73.8M | $84.8M | ||
| Average Shares Outstanding (Diluted) | $17.7M | $44.8M | $73.8M | $84.8M | ||
| Shares Outstanding | $41.3M | $66.9M | $163.0M | $87.6M | ||
| Basic EPS | $-4.1 | $-2.76 | $-1.68 | $-1.31 | ||
| Basic EPS (Continuing Operations) | $-4.1 | $-2.76 | $-1.68 | $-1.31 | ||
| Diluted EPS | $-4.1 | $-2.76 | $-1.68 | $-1.31 | ||
| Diluted EPS (Continuing Operations) | -- | $-2.76 | $-1.68 | $-1.31 | ||
| OTHER METRICS | ||||||
| Other Gand A | $18.4M | $31.1M | $33.2M | $29.2M | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TNYA | $1.41 | 0% | 2.78M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tenaya Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW